JPRN-UMIN000051528
Not Yet Recruiting
N/A
A retrospective study to explore the biomarkers in lung cancer immunotherapy, 2nd stage -irAE prediction- - Immuno-Oncology Biomarker Study-II_irAE (LC-SCRUM-IBIS-II_irAE)
ational Cancer Center Hospital East0 sites350 target enrollmentJuly 6, 2023
Conditionsung cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ung cancer
- Sponsor
- ational Cancer Center Hospital East
- Enrollment
- 350
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Not applicable
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
A prospective observational study of biomarkers for Second-line FOLFIRI plus Aflibercept treatment in patients with metastatic colorectal cancer comparing to FOLFIRI plus beVacizumab: an Exploratory biomarker study.colorectal cancerJPRN-UMIN000038508Kyoto University Hospital70
Recruiting
N/A
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125
Active, Not Recruiting
Phase 1
Biomarkermoderate-to-severe psoriasisMedDRA version: 19.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002588-40-DEniversity Hospital Schleswig-Holstein40
Recruiting
N/A
An exploratory investigation of the biomarker for senescence and arteriosclerosis in renal transplant donors and recipients.Recipients and donors in living-kidney transplantationJPRN-UMIN000004905Kagawa University, Faculty of Medicine45
Recruiting
N/A
A biomarker assessment study to investigate the influence of high-frequency chest wall oscillations on the clearance of cerebrospinal fluid biomarkersNL-OMON51372Centre for Human Drug Research34